Unfortunately, I’m in the middle of writing this month’s Bio-Materials newsletter for Tecnon OrbiChem so blog posts are brief and few.
Here’s a recent announcement from Corbion Purac about its planned acquisition of Malladi Specialties Limited (MSL), a leading manufacturer in India of lactic acid and lactic acid-based derivatives such as calcium lactate, sodium lactate and buffered lactic acid for pharmaceutical, home and personal care, chemical and food applications.
The transaction includes sales and delivery of lactic acid and lactic acid-based derivatives in India. No production facilities will be acquired. Production will remain with Malladi Drugs and Pharmaceuticals Limited (MDPL), which is is also part of the Malladi Group, the parent company of MSL.
MDPL will produce derivatives on behalf of Corbion Purac. This transaction reportedly allows for a local production base through the partnership, while maintaining control on quality supplied to Corbion’s customers.